Gannex Announces Positive Clinical Results in Overweight and Obese Subjects for Its THR-β Agonist ASC41

PR Newswire
February 21, 2021 — 19:30 CST

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!

Already have an account or paid subscription? Log in

Related Topics: biotech China healthcare Hong Kong manufacturing Shanghai stock exchange stock market technology

Related News:

Ecogensus Develops Novel New Sustainable Resource: Plastic Substitutes Derived from Mixed Household Wastes

May 3, 2024 — 09:15

CFGI Acquires Leading German CFO Advisory Firm PAS Financial Advisory AG

May 3, 2024 — 09:00

QANDA Named to TIME’s Inaugural List of the World’s Top EdTech Companies in 2024

May 3, 2024 — 07:27

Integrated cancer biotech Infinitopes secures £12.8m seed financing to enhance its Precision Immunomics™ antigen discovery technologies to target five more cancers

May 2, 2024 — 07:01

MGM China Reports 2024 First Quarter Results

May 2, 2024 — 06:16

Chinese president’s upcoming visit to bring new hope to Serbia’s development: Vucic

May 1, 2024 — 11:51

GoDaddy: Six Tips for building a website that really works for your business

May 1, 2024 — 01:22

Chinese new energy industry contributes to global green, low-carbon transition

April 30, 2024 — 15:13

LYB to build integrated plastic waste recycling hub in Knapsack

April 29, 2024 — 19:00